Lv51
840 积分 2024-04-24 加入
Impurities in Oligonucleotide Drug Substances and Drug Products
4个月前
已完结
CMC and regulatory aspects of oligonucleotide therapeutics
4个月前
已完结
烟曲霉对唑类药物耐药研究的最新进展
6个月前
已完结
N-acetylgalactosamine delivery systems for RNA therapeutics: a patent perspective
9个月前
已完结
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
9个月前
已完结
Sustainability in Tides Chemistry: Green Approaches to Oligonucleotides and Olig
11个月前
已完结
Genotoxicity evaluation of a valsartan-related complex N-nitroso-impurity
1年前
已完结
皖公网安备34019202002308
